79 related articles for article (PubMed ID: 2297711)
1. Tumor spheroid model for the biologically targeted radiotherapy of neuroblastoma micrometastases.
Walker KA; Mairs R; Murray T; Hilditch TE; Wheldon TE; Gregor A; Hann IM
Cancer Res; 1990 Feb; 50(3 Suppl):1000s-1002s. PubMed ID: 2297711
[TBL] [Abstract][Full Text] [Related]
2. A tumour spheroid model for antibody-targeted therapy of micrometastases.
Walker KA; Murray T; Hilditch TE; Wheldon TE; Gregor A; Hann IM
Br J Cancer; 1988 Jul; 58(1):13-6. PubMed ID: 3166889
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
4. The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroids.
Mairs RJ; Angerson W; Gaze MN; Murray T; Babich JW; Reid R; McSharry C
Br J Cancer; 1991 Mar; 63(3):404-9. PubMed ID: 2003981
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.
Lee YS; Bullard DE; Zalutsky MR; Coleman RE; Wikstrand CJ; Friedman HS; Colapinto EV; Bigner DD
Cancer Res; 1988 Feb; 48(3):559-66. PubMed ID: 2446747
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic application of radiolabeled monoclonal antibody UJ13A in children with disseminated neuroblastoma.
Lashford L; Jones D; Pritchard J; Gordon I; Breatnach F; Kemshead JT
NCI Monogr; 1987; (3):53-7. PubMed ID: 3821919
[TBL] [Abstract][Full Text] [Related]
7. A gene therapy/targeted radiotherapy strategy for radiation cell kill by.
Boyd M; Mairs RJ; Cunningham SH; Mairs SC; McCluskey A; Livingstone A; Stevenson K; Brown MM; Wilson L; Carlin S; Wheldon TE
J Gene Med; 2001; 3(2):165-72. PubMed ID: 11318115
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
Bruchelt G; Girgert R; Buck J; Wolburg H; Niethammer D; Treuner J
Cancer Res; 1988 Jun; 48(11):2993-7. PubMed ID: 3365688
[TBL] [Abstract][Full Text] [Related]
9. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A
Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344
[TBL] [Abstract][Full Text] [Related]
10. 131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.
Langmuir VK; McGann JK; Buchegger F; Sutherland RM
Cancer Res; 1989 Jun; 49(12):3401-6. PubMed ID: 2720694
[TBL] [Abstract][Full Text] [Related]
11. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
[TBL] [Abstract][Full Text] [Related]
12. Oxygen tensions in two human tumor cell lines grown and irradiated as multicellular spheroids.
Schwachöfer JH; Acker H; Crooijmans RP; Van Gasteren JJ; Holtermann G; Hoogenhout J; Jerusalem CR; Kal HB
Anticancer Res; 1991; 11(1):273-9. PubMed ID: 2018361
[TBL] [Abstract][Full Text] [Related]
13. Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model.
Kwok CS; Crivici A; MacGregor WD; Unger MW
Cancer Res; 1989 Jun; 49(12):3276-81. PubMed ID: 2720681
[TBL] [Abstract][Full Text] [Related]
14. Nuclear medicine therapy of neuroblastoma.
Hoefnagel CA
Q J Nucl Med; 1999 Dec; 43(4):336-43. PubMed ID: 10731784
[TBL] [Abstract][Full Text] [Related]
15. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
16. Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine.
Boyd M; Cunningham SH; Brown MM; Mairs RJ; Wheldon TE
Gene Ther; 1999 Jun; 6(6):1147-52. PubMed ID: 10455418
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
[TBL] [Abstract][Full Text] [Related]
18. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
Badger CC; Krohn KA; Peterson AV; Shulman H; Bernstein ID
Cancer Res; 1985 Apr; 45(4):1536-44. PubMed ID: 3978621
[TBL] [Abstract][Full Text] [Related]
19. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
20. Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma.
Mairs RJ; Angerson WJ; Babich JW; Murray T
Prog Clin Biol Res; 1991; 366():495-501. PubMed ID: 2068165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]